Premium
Cyberknife treatment in adenoid cystic carcinoma of the lacrimal gland
Author(s) -
Tunc M.,
Guney Y.
Publication year - 2016
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.2016.0299
Subject(s) - cyberknife , adenoid cystic carcinoma , medicine , radiation therapy , lacrimal gland , adenoid , radiology , orbit (dynamics) , carcinoma , surgery , radiosurgery , pathology , engineering , aerospace engineering
Purpose To determine the effectiveness of Cyberknife radiotherapy in Adenoid Cystic Carcinoma of the lacrimal gland. Methods Five patients with pathologically proven adenoid cystic carcinoma of the orbit were included in our study. All received 1–2 sessions of Cyberknife treatement in between 1–5 fractions after surgical resection of the tumor. Clinical characteristics and outcome of treatment were discussed in depth. Results All patients except one case were under 25 years old at diagnosis. Bone involvement was present in four cases. Tumor was removed as much as possible in all cases. All patients received additional cyberknife radiotherapy for the residual tumor. Tumor recurrence was seen in four cases and additional surgical resection was required in all. Additional second session Cyberknife was applied in two cases. One of these two developed radiation induced keratopathty, none developed radiation retinopathy. Conclusions Cyberknife radiotherapy is an effective and repeatable method in adenoid cystic carcinoma of the orbit.